ClinicalTrials.gov record
Completed Phase 3 Interventional

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

ClinicalTrials.gov ID: NCT00547651

Public ClinicalTrials.gov record NCT00547651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AMR PH GL 2007 CL001 Phase 3 A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Study identification

NCT ID
NCT00547651
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
637 participants

Conditions and interventions

Interventions

  • Amrubicin Drug
  • Topotecan Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2007
Primary completion
Apr 30, 2011
Completion
Apr 30, 2011
Last update posted
Nov 5, 2019

2007 – 2011

United States locations

U.S. sites
61
U.S. states
29
U.S. cities
60
Facility City State ZIP Site status
Northwest Alabama Cancer Center Muscle Shoals Alabama 35661
Arizona Oncology Associates Tucson Arizona 85704
Little Rock Hematology Oncology Associates Little Rock Arkansas 72205
Cancer Care Associates of Fresno Medical Group, Inc. Fresno California 93720
Cedars-Sinai Outpatient Cancer Center Los Angeles California 90048
University of Colorado Health Science Centre Aurora Colorado 80045
Rocky Mountain Cancer Center - Midtown (Main) Denver Colorado 80218
Advanced Medical Specialties Miami Florida 33176
Ocala Oncology Center Ocala Florida 34474
Cancer Centers of Florida, P.A. Ocoee Florida 34761
Florida Oncology Associates Orange Park Florida 32073
Sacred Heart Medical Oncology Pensacola Florida 32504
Medical Oncology Associates of Augusta Augusta Georgia 30809
Joliet Oncology-Hematology Associates, Ltd. Joliet Illinois 60435
Cancer & Hematology Specialists of Chicago (Main) Niles Illinois 60714
Illinois Cancer Care Peoria Illinois 61615
Cancer Care at Blessing Hospital Quincy Illinois 62301
Central Indiana Cancer Centers Indianapolis Indiana 46227
Hope Center Terre Haute Indiana 47802
Kansas City Cancer Center (Main) Overland Park Kansas 66210
Cancer Center of Kansas Wichita Kansas 67214
Jayne Gurtler MD, Laura Brizn MD, Angelo Russo MD, and Janet Burroff MD, APMC Metairie Louisiana 70006
Tulane University Health Sciences Center New Orleans Louisiana 70112
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074
Sinai Hospital of Baltimore, Inc. Baltimore Maryland 21215
Center for Cancer and Blood Disorders Bethesda Maryland 20817
Alliance Hematology Oncology, P.A. (Main) Westminster Maryland 21157
Kalamazoo Hematology and Oncology Kalamazoo Michigan 49048
Michigan Hematology & Oncology Institute Southgate Michigan 48195
University of Minnesota Medical Center, Cancer Center Minneapolis Minnesota 55455
Missouri Cancer Associates Columbia Missouri 65201
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507
Comprehensive Care Centers of Nevada (Main) Las Vegas Nevada 89169
New York Oncology Hematology, P.C. Latham New York 12110-0610
SUNY Upstate Medical University - Regional Oncology Center Syracuse New York 13210
Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
Regional Cancer Care Durham North Carolina 27704
Cancer Centers of North Carolina (Main) Raleigh North Carolina 27607
Piedmont Hematology Oncology Associates Winston-Salem North Carolina 27103
Gabrail Cancer Center Canton Ohio 44718
Greater Dayton Cancer Center (Main) Kettering Ohio 45409
Cancer Care Associates Oklahoma City Oklahoma 73112
Cancer Care Associates Tulsa Oklahoma 74136
Willamette Valley Cancer Center (Main) Eugene Oregon 97401-8122
Medical Oncology Associates Kingston Pennsylvania 18704
Thomas Jefferson Memorial Hospital Philadelphia Pennsylvania 19107
UPMC Cancer Pavilion Pittsburgh Pennsylvania 15232
Cancer Centers of the Carolinas (Main) Greenville South Carolina 29615
The Sarah Cannon Research Institute/TN Oncology Nashville Tennessee 37203
Texas Oncology, P.A. Amarillo Texas 79106
Coastal Bend Cancer Center Corpus Christi Texas 78463
Texas Cancer Center at Medical City (Main) Dallas Texas 75230-2510
Texas Oncology, P.A. (Main) Dallas Texas 75246
West Texas Cancer Center-Texas Oncology Odessa Texas 79761
Texas Oncology, P.A. Webster Texas 77598-4420
Texoma Cancer Center Wichita Falls Texas 76310
Fairfax Northern Virginia Hematology/Oncology Fairfax Virginia 22031
Virginia Oncology Associates Norfolk Virginia 23502
Blue Ridge Cancer Care Roanoke Virginia 24019
Northwest Cancer Specialists - Vancouver (Main) Vancouver Washington 98684
Marshfield Clinic Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00547651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2019 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00547651 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →